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The solution and complexation chemistry of zinc ions is the basis for zinc biology. In living organisms,
zinc is redox-inert and has only one valence state: Zn(II). Its coordination environment in proteins is
limited by oxygen, nitrogen, and sulfur donors from the side chains of a few amino acids. In an estimated
10% of all human proteins, zinc has a catalytic or structural function and remains bound during the
lifetime of the protein. However, in other proteins zinc ions bind reversibly with dissociation and as-
sociation rates commensurate with the requirements in regulation, transport, transfer, sensing, signal-
ling, and storage. In contrast to the extensive knowledge about zinc proteins, the coordination chemistry
of the “mobile” zinc ions in these processes, i.e. when not bound to proteins, is virtually unexplored and
the mechanisms of ligand exchange are poorly understood. Knowledge of the biological inorganic
chemistry of zinc ions is essential for understanding its cellular biology and for designing complexes that
deliver zinc to proteins and chelating agents that remove zinc from proteins, for detecting zinc ion
species by qualitative and quantitative analysis, and for proper planning and execution of experiments
involving zinc ions and nanoparticles such as zinc oxide (ZnO). In most investigations, reference is made
to zinc or Zn2þ without full appreciation of how biological zinc ions are buffered and how the d-block
cation Zn2þ differs from s-block cations such as Ca2þ with regard to signiﬁcantly higher afﬁnity for li-
gands, preference for the donor atoms of ligands, and coordination dynamics. Zinc needs to be tightly
controlled. The interaction with low molecular weight ligands such as water and inorganic and organic
anions is highly relevant to its biology but in contrast to its coordination in proteins has not been dis-
cussed in the biochemical literature. From the discussion in this article, it is becoming evident that zinc
ion speciation is important in zinc biochemistry and for biological recognition as a variety of low mo-
lecular weight zinc complexes have already been implicated in biological processes, e.g. with ATP,
glutathione, citrate, ethylenediaminedisuccinic acid, nicotianamine, or bacillithiol.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Proteins are the major ligands for zinc(II) ions (“zinc”). Zinc can
be readily available from proteins or not available at all unless the
protein is degraded. In a way, the coordination chemistry of zinc in
proteins bridges the one in natural waters, where zinc is in an
available form, and the one in minerals, where zinc is unavailable
without chemical processing. Zinc is essential for virtually all
cellular functions through its presence in an estimated 3000Cutting Edge of Zinc Biology,
ki Fukada.
el), wolfgang.maret@kcl.ac.uk
r Inc. This is an open access articlehuman proteins, the zinc sites of which have been predicted by
bioinformatics approaches from the signature motifs in their pro-
tein sequences [1]. If one considers additional functions of zinc in
regulation, the number of zinc proteins in the human zinc prote-
ome will be even larger [2]. The coordination chemistry of zinc in
proteins and peptides involves N, O, and S donors of the side chains
of histidine, glutamate/aspartate, and/or cysteine with any per-
mutation of these ligands and with the number of protein ligands
ranging from three to six. The ligands may not stem from a single
protein but from up to four proteins. One property regularly cited
for zinc is its ﬂexibility in coordination due to the lack of ligand ﬁeld
stabilization. This allows for dynamic coordination environments of
zinc ions, which is critical for example in its catalytic prowess in
enzymes when adopting different coordination numbers in in-
teractions with substrates. A critical chemical issue that isunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Using a limited number of ligand donors and geometries, proteins
must control and adjust afﬁnities for zinc according to physiological
functions. These functions are determined by the structural prop-
erties of zinc binding sites such as the presence of a second coor-
dination sphere that engages in hydrogen bonding to ligands,
including water molecules when present, geometric strains
(entasis), pockets with different dielectric constants (hydrophobic
cores), all of which modulate the properties of the bound zinc. For
example, in zinc ﬁngers with a bba fold and in zinc-containing LIM
domains, hydrogen bonds and hydrophobic and electrostatic in-
teractions around the bound zinc affect binding and exchange ki-
netics [3,4]. Such stabilization through interactions in the second
coordination sphere, though not always directly obvious from in-
spection of the protein structure, occurs in both intra- or inter-
molecular zinc binding sites and is responsible for stabilizing some
sites to afﬁnities for zinc as high as femtomolar in zinc-binding
domains such as the zinc hook [5]. A lack or a limited number of
stabilizing secondary interactions also can have the opposite effect,
namely decreasing afﬁnities of proteins for zinc as a way of con-
trolling their function [6]. Zinc coordination in proteins has been
reviewed and catalogued extensively and hence is not the subject of
this article. An important subject that has not been reviewed in the
literature, however, is the biological coordination chemistry of zinc
ions when not bound to proteins e the focus of this article. This
subject matter is important with regard to the way zinc is
controlled in biology and the functions of zinc as a signalling ion as
discussed in many articles in this special issue.2. The relationship between protein-bound and “free zinc”
and the role of zinc ions in cellular signalling
Biologically essential divalent metal ions are regulated in cells in
ranges of concentrations that follow the Irving-Williams series [7].
If metal ions were not buffered in certain ranges, each metal ion
would not be capable of performing its speciﬁc functions because
the coordination environments of proteins are not sufﬁciently se-
lective for a particular metal ion. Zinc binds with rather high af-
ﬁnities tometal sites of proteins and therefore is highly competitive
towards other metal ions binding with lower afﬁnities. Character-
istic for the interaction of zinc ions with intracellular (i) or extra-
cellular (e) proteins (P) is an equilibrium far to the left (Eq. (1)).
ZnP%Pþ
h
Zn2þ
i
i;e
(1)
In order for zinc not to bind to metal sites for iron, for example,
the concentrations of zinc ions must be kept sufﬁciently low
despite the fact that total cellular zinc concentrations are rather
high, ie. about 200 mM. This control is achieved by buffering zinc in
a range of relatively low pZn (log[Zn2þ]free), a situation quite
different from solutions of zinc salts in water or in most biological
buffers where zinc is not buffered. The term “zinc buffering” is
based on the pH buffering concept, where an appropriate pH value
is controlled by the ratio between a protonated form (HA), formally
an acid according to the BrønstedeLowry theory, and a deproto-
nated form of the buffer component (A), formally a base, and the
acid dissociation constant of HA (pKa) (Eq. (2), the Hender-
soneHasselbalch equation). Likewise zinc buffering and pZn are
determined by both species of the zinc buffering components, ie.
the ratio between the metallated holo-form of the zinc complex
ZnP (if the ligand is a protein, P) and the demetallated apo-form P,
and the dissociation constant (pKd) of the ZnP complex (Eq. (3)) [8].
Zinc buffering must occur in away to havemost zinc enzymes 100%
metallated to be functional. In cultured HT29 colon cancer cells,about 10% of sites with high afﬁnity (Kd ¼ 83 pM) were found to be
demetallated, thus contributing to a ~10/90% buffer ratio under
these conditions [9].
pH ¼ pKa þ log
 
A

½HA
!
(2)
pZn ¼ pKd þ log
 ½P
½ZnP

(3)
The concentrations of “free” zinc ions in the cytosol of cells have
been estimated to be in the range of a few hundred picomolar
under steady-state conditions [9,10]. They can ﬂuctuate only in a
rather narrow range to avoid deﬁciency and toxicity. The efﬁcient
zinc buffering is achieved by high afﬁnity binding to proteins and
transport processes that also control the concentrations of zinc. In
order to allow for and control pre-steady state ﬂuctuations of zinc
ions, an additional process participates, namely the transport of
excess zinc ions into a subcellular store. This kinetic process con-
tributes to thermodynamic buffering and is called mufﬂing [11]. A
mufﬂer binds zinc ions and transports them from the cytosol to a
vesicular compartment where they are sequestered. Mufﬂing al-
lows the cell to cope with higher zinc ion ﬂuctuations without the
need for high buffering capacity and makes possible zinc ion ﬂuxes
and signalling in an otherwise metal-buffered environment. Buff-
ering and mufﬂing have a limited capacity. Yet, they avoid that zinc
ions reach higher concentrations to displace other metal ions from
their binding sites or to bind to target sites that are normally not
occupied with metal ions.
On the other hand, sufﬁcient zinc ions must be available to
supply zinc-requiring proteins. Zinc is released during protein
turnover, transported into the cell and out of the cell, and further
re-distributed among cellular compartments. The control of total
and “free” zinc ion concentrations also involves ﬂuctuating zinc ion
concentrations that regulate biological processes. Increased cellular
zinc ion concentrations (“zinc ion transients” or “zinc signals”) are
generated during mobilization of zinc ions from proteins by
chemical processes that modify the protein or release of zinc ions
from organellar/vesicular stores, where zinc is stored in a yet to be
determined chemical form (Eq. (4)).
ZnP/P*þ
h
Zn2þ
i
i;e
where P  denotes a modified protein
(4)
Similar to the release of calcium ions, hormones were shown to
stimulate the release of zinc ions from the endoplasmic reticulum
(ER) [12]. However, an examination of epidermal growth factor/
ionomycin stimulated breast cancer cells employing genetically
encoded FRET sensors for zinc could not detect the release of zinc
ions [13]. Signallingwith oxidative species also can release zinc ions
from coordination environments of zinc with sulfur donors from
cysteine in proteins, linking redoxmetabolism and zincmetabolism
and converting redox signals into zinc signals [14]. While the hy-
drated Ca2þ ion is the major species in calcium signalling, this is not
the case in zinc signalling as the Zn2þ ion has much higher afﬁnities
for donors of ligands.
Furthermore, some cells release zinc ions and increase extra-
cellular zinc concentrations. The pool of zinc ions that is not bound
to proteins is functionally signiﬁcant and has been variously
referred to as “labile zinc”, “free zinc”, “fast-exchanging zinc”, and
“mobile zinc.” All these operational deﬁnitions are unsatisfactory as
chemical terms. The use of these terms has resulted in considerable
ambiguities. In the entire biochemical literature, the zinc ions not
bound to proteins are not speciﬁed in terms of their coordination
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think of “free” zinc as its aquo complex. The chemist understands
“free” zinc as the ion without ligands, which exists only in the gas
phase. However, given the large number of potential ligands inside
and outside cells, and the dynamic changes of ligands and zinc
concentrations, non-protein bound (“free”) zinc is expected to have
different types of LMW ligands under various biological conditions,
including inorganic and organic anions, and in this regard it is quite
different from Ca2þ. The lack of understanding the chemical nature
of the pool of non-protein bound zinc is a major limitation in
interpreting experiments and in planning experiments with
conclusive outcomes. In this article, we attempt to address this
issue by discussing the solution chemistry of zinc ions and then
relating it to the biological coordination chemistry, with an
emphasis on quantitative concepts and the constraints imposed by
cells. This treatment results in a focus on those aspects of zinc
chemistry that are important for biology, nutrition, pharmacology
and toxicology, and for investigating the biology of zinc with
ﬂuorescent probes. The characteristic coordination chemistry of
zinc is a key to understanding its physiological and pathophysio-
logical functions in living organisms.3. Zinc speciation
The speciation of zinc is illustrated best with a Pourbaix diagram
(Fig. 1). Such a diagram shows chemical species as a function of
both redox standard potential and pH values, and demonstrates a
remarkable property of zinc that is critical for its functions in
biology: In the absence of other coordinating ligands, zinc is present
as hydrated Zn2þ(aq), over the entire ranges of redox potentials and
pH values in biology. The orange arrow in Fig. 1 indicates the range
of biologically important standard potentials determined at pH 7.4.
Even for the lowest half reactions of the reductions of acetate toFig. 1. Pourbaix diagram for the speciation of zinc. Red and green dashed lines
demonstrate two possible cathodic reactions, oxygen reduction (oxygen dissolved in
water in equilibrium with water) and hydrogen ion reduction (water in equilibrium
with gaseous hydrogen), respectively. The orange arrow shows the range of biological
standard reduction potentials at pH 7.0: from ~820 mV to ~ 670 mV.acetaldehyde (581 mV) or succinate to a-ketoglutarate
(670 mV) zinc maintains its the þ2 oxidation state [15]. In other
words, zinc is redox-inert in biology and therefore its redox prop-
erties are irrelevant. Therefore, we refer to zinc in the þ2 oxidation
state (Zn(II)) simply to zinc in this article though this term is
reserved to the element in the 0 oxidation state in chemistry. In
biology, many ligands are present and the species observed as a
function of the concentrations of these ligands and pH are relevant
as they modify the behavior of zinc ions. The resulting implications
for function are discussed in this article.3.1. Zinc(II) aquo complexes and hydroxides
The Pourbaix diagram (Fig. 1) does not imply that hydrated
Zn2þ(aq) is a single species. The chemistry of the zinc ion in water is
fundamental, rather complex, and has important consequences for
the role of zinc in biology. Water is both a Lewis base, coordinating
as a ligand via its oxygen atom to the zinc ion, and a Lewis acid,
coordinating to donors with negative charges via its hydrogen
atoms. Binding of water molecules is electrostatic in nature for al-
kali metal ions, such as Naþ and Kþ, but has signiﬁcant covalent
character for transition metal ions including zinc ions. The covalent
character of the zinc ion/water interaction is conﬁrmed by a high
heat of zinc ion solvation of ~ 500 kcal/mol in aqueous solutions
[16]. Assuming six water molecules (hexaaquo complex) bound to a
central zinc ion, the enthalpy of solvation for one water molecule
is ~ 80 kcal/mol, which corresponds to typical values for covalent
Zn-O bond formation (70 to 85 kcal/mol).
Zn2þ has a ﬁlled d-shell ([Ar]d10 electron conﬁguration) and
consequently no ligand ﬁeld stabilization energies and associated
stereochemical preferences. Therefore, coordination number and
geometry of zinc complexes are determined mainly by the radii of
both themetal ion and the coordinating ligand atoms or ions and its
aquo complexes have quite ﬂexible coordination geometry. Besides
the commonly described hexaaquo complex [Zn(H2O)6]2þ, there is
also a tetraaquo complex [Zn(H2O)4]2þ. In the solid state, a penta-
coordinate [Zn(H2O)5]2þ complex has also been found [17]. Ab initio
calculations show that hexa-, penta- and tetraaquo zinc complexes
differ by less than 0.4 kcal/mol, which is in contrast with other
divalent cations such as magnesium. It is in agreement with the
biological roles of the cations. The coordination of magnesium is
mostly octahedral whereas zinc ions are bound to sulfur, nitrogen
or oxygen donors with coordination dynamics linked to catalysis
[18].
Zinc aquo complexes are acids according to the BrønstedeLowry
theory. The polarization of water molecules by the central zinc ion
causes dissociation of a proton, resulting in the formation of an
aquo-hydroxo complex (Eq. (5)). The equation solved for the con-
centrations of protons [H3Oþ] is the non-logarithmic form of the
Henderson-Hasselbalch equation describing pH buffering of a zinc
salt in the range of pH within ±1 of the pKa (pKa1 ¼ 9.05) of hy-
drolysis of the hexaaquo complex [19] (Eq. (6)).

ZnðH2OÞ6
2þ þ H2O%ZnðOHÞðH2OÞ5þ þ H3Oþ (5)
½H3Oþ ¼ Ka1

ZnðH2OÞ6
2þ
ZnðOHÞðH2OÞ5
þ (6)
All zinc salts of strong acids (chloride, nitrate, sulfate or
perchlorate) are weak acids as indeed observed in pH-metric
measurements. The pH value of a solution of a zinc salt in water
can be calculated from Eq. (7), which is derived from Eq. (6) under
the assumptions that the concentrations of H3Oþ and
[Zn(OH)(H2O)5]þ are the same and the concentration of
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the zinc salt.
pH ¼ 0:5pKa1  0:5 logðcsÞ (7)
Based on Eq. (7) a 0.05 M solution of a zinc salt inwater has a pH
of 5.18. The higher the zinc salt concentration the lower is the pH
value. This pH value refers to solution of a zinc salt with an unde-
ﬁned anion. In practice, the pH of solutions of zinc salts depends not
only on concentrations but also on the chemical composition of the
salt. Solutions of zinc salts therefore can be acidic, neutral or even
slightly basic with pH ¼ 7 (neutral) as the relative reference point
on the acid-base scale. For example, the pH values of 1e10% (w/w)
ZnSO4,7H2O (0.035e0.35 M) or ZnCl2 (0.074e0.74 M) solutions are
between 4.4 and 5.9 depending on the commercial source of the
salt. These pH values are in good agreement with calculations ob-
tained from Eq. (7). However, the pH values of 1e10% Zn(OAc)2
(0.05e0.55 M) solutions are between 6.0 and 8.0, which is signiﬁ-
cantly different from those of the above mentioned salts. The origin
of the difference in pH values is the acid-base properties of the
anion. Because sulfate and chloride are anions of strong acids, they
are extremely weak bases and do not affect the pH of the aqueous
solution. The reason for the different behavior observed for zinc
acetate, citrate, or formate solutions is that these anions have basic
character and hence oppose the effects on pH due to [Zn(H2O)6]2þ
hydrolysis. Acetate reacts with water according to Eq. (8) and de-
creases the pH.
CH3COO
 þ H2O%CH3COOHþ OH (8)
The pKb (¼ pKw - pKa) value of the acetate/acetic acid pair is 9.2
and similar to the pKa1 of [Zn(H2O)6]2þ (Eq. (6)). Because these
opposing effects cancel each other, the pH values of Zn(OAc)2$nH2O
solutions are neutral despite the fact that cation and anion have
acid-base properties. For practical purposes, it is important to note
that the pH value of zinc salts varies slightly depending on manu-
facturers and impurities, the carbon dioxide concentration, and the
time of storage. It is also useful to remember that zinc salts with
anions of strong acids have low pH-buffering capacity. Therefore,
addition of a pH buffer at physiological pH to a solution of ZnCl2 will
immediately change the pH of the solution, possibly resulting in the
precipitation of zinc hydroxide. On the other hand, a Zn(OAc)2 so-
lution is a better pH-buffer. Its pH-buffering capacity depends on its
concentration and therefore preparation of too concentrated solu-
tions also may result in a pH that causes precipitation of zinc hy-
droxide. In summary, zinc salt solutions in biological buffers
without capacity for zinc complexationmay provide a rather poorly
controlled source of zinc ions for biological experiments.
Amphoteric characteristics of zinc aquo complexes are evident
from further deprotonation of water molecules and formation of
hydroxo species. The octahedral zinc hexaaquo complex
[Zn(H2O)6]2þ is in equilibrium with tetrahedral [Zn(H2O)4]2þ with
an equilibrium constant much in favor of the former. For simplicity,
the equilibria of aquo complexes with various geometry,
[Zn(H2O)x]2þ will refer to either hexaaquo (x ¼ 6) or tetraaquo
(x ¼ 4) complexes in this article. Vibrational spectroscopic in-
vestigations on aqueous solutions of zinc salts demonstrated for-
mation of the tetraaquo complex at high salt concentrations where
the water content decreases signiﬁcantly [20]. The zinc pentaaquo-
hydroxo complex also is in equilibrium with the octahedral and
tetrahedral species. The conversion of [Zn(OH)(H2O)5]þ to
[Zn(OH)(H2O)3]þ has not been described in detail in terms of its
equilibrium constant/energetics. The dissociation of another water
molecule results in the formation of a neutral [Zn(OH)2(H2O)x-2](aq)
species. The octahedral species [Zn(OH)2(H2O)4](aq) is less favored
due to additional charge compensation and stronger repulsion ofnegatively charged ligands, all of which favor the tetrahedral
[Zn(OH)2(H2O)2](aq) species. Ab initio calculations show that the pKa
value for the dissociation of a proton from a water molecule bound
to an octahedral zinc complex is about 0.8 logarithmic units higher
compared to that from awatermolecule bound to a tetrahedral zinc
complex [21]. This phenomenon is important for enzyme catalysis,
where a tetrahedral zinc(II) provides a signiﬁcant advantage in
terms of providing a higher fraction of the hydroxo species as a
nucleophile at physiological pH. The chemistry of aquo and aquo-
hydroxo species of zinc is quite different from calcium and in
addition to functions in proteins may be important in biological
recognition of zinc. Macromolecules sometimes select a minor
species from an assembly of species as a ligand or substrate.
Due to our limited knowledge regarding equilibria between
octahedral and tetrahedral zinc aquo-hydroxo complexes, these
complexes are frequently presented in a simpliﬁedway as Zn(OH)þ,
Zn(OH)2(aq), Zn(OH)3- and Zn(OH)42 which is a simpliﬁcation
focusing only on the number of hydroxo ligands. The stepwise
proton dissociation constants of the second (pKa2 ¼ 9.75), third
(pKa3 ¼ 10.1) and fourth (pKa4 ¼ 10.5) water molecule bound to the
central zinc ion are average values of the dissociation constants of
both octahedral and tetrahedral species, the molar fraction of
which changes with pH [19]. Eqs. (9)e(11) present stepwise dis-
sociations of all zinc aquo-hydroxo complexes. The ﬁnal product,
the [Zn(OH)4]2- complex (zincate), is tetrahedral and has no cova-
lently bound water molecules because of its high negative charge.
This charge effect forces octahedral complexes present at acidic and
neutral pH into a tetrahedral complexes at alkaline pH.

ZnðOHÞðH2OÞx1
þ þ H2O%ZnðOHÞ2ðH2OÞx2ðaqÞ þH3Oþ
(9)

ZnðOHÞ2ðH2OÞx2

ðaqÞ þ H2O%

ZnðOHÞ3ðH2OÞx3
 þ H3Oþ
(10)

ZnðOHÞ3ðH2OÞx3
 þ H2O%ZnðOHÞ42 þ H3Oþ (11)
where x ¼ 4 or 6 depending on complex geometry.
The pH dependence of the aquo-hydroxo complexes is based on
these equilibria (Fig. 2). The deprotonation of coordinated water
molecules begins at slightly alkaline pH, above 7.8 (5% of
[Zn(OH)(H2O)x-1]þ), and terminates with the fully deprotonated
species above pH 11.8 (95% of [Zn(OH)4]2-). The concentration of the
uncharged complex, [Zn(OH)2(H2O)x-2](aq), is highest at pH 9.9 and
decreases above that value.
Solid ZnO is formed by calcination (heating at high tempera-
tures) from Zn(OH)2(s) and widely used in nutritional and some
research applications. A discussion of the properties of Zn(OH)2(s)
and ZnO illustrates the issues associated with the dissolution of
different forms of these compounds and hence availability of zinc
for biological systems. Precipitation of solid zinc hydroxide
Zn(OH)2(s) observed in mildly alkaline aqueous solutions is strictly
related to the presence of the uncharged, but water soluble
[Zn(OH)2(H2O)x-2](aq) species. Transition from the soluble to the
insoluble form requires the dissociation of water. The type of
Zn(OH)2(s) crystals formed depend on the total zinc concentration,
pH, and temperature. Six forms of Zn(OH)2(s) have been described
so far, and they are known as a (amorphous) and crystalline b1, b2,
g, d and ε. They havewidely variable solubility inwater according to
the series: amorphous > b1 ~ g > b2 > ε [22]. Another confounding
variable in the determination of the solubility is the use of ZnO. In
this case, the solubility and thermodynamic equilibration of
Fig. 2. The pH dependence of ﬁve zinc aqua-hydroxo complexes in water solution. a)
Molar fraction distribution of particular zinc species as a function of pH. b) Logarithmic
plot of the concentration of particular species [17]. Black, red, green, blue and magenta
color lines correspond to [Zn(H2O)x]2þ, [Zn(OH)(H2O)x-1]þ, [Zn(OH)2(H2O)x-2](aq),
[Zn(OH)3(H2O)x-3]-, and [Zn(OH)4]2-, respectively.
Fig. 3. The pH dependence of the solubility of zinc hydroxide (ε-Zn(OH)2(s)) [20]. The
ordinate indicates on a logarithmic scale the sum of all zinc soluble species present at a
particular pH (Zn2þ(aq)) which include aquo- and hydroxocomplexes presented in
Fig. 2. The dashed line indicates the log[Zn2þ(aq)] value at pH 7.4.
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ZnO to yield Zn(OH)2(s) and soluble species of the type [Zn(OH)2(-
H2O)x-2](aq). Furthermore, ε-Zn(OH)2(s) is unstable with respect to
ZnO(s) and H2O and also with respect to amorphous Zn(OH)2(s), and
the conversion between the various forms of Zn(OH)2(s) and ZnO is
often slow [22]. ZnO has lower solubility compared to the amor-
phous form of Zn(OH)2(s) (one order of magnitude difference in
KSO). Clear differences in the kinetics of transition between ZnO and
different forms of Zn(OH)2 and in their solubilities are the reason
why different procedures result in the production of different forms
of ZnO.
Best characterized is the solubility of the orthorhombic form
ε-Zn(OH)2(s) with a KSO of 3.39  1017 (pKSO ¼ 16.47) at 25 C and
I ¼ 0.2 M [22]. Based on the solubility product (KSO ¼ [Zn2þ(aq)]
[OH]2) and the ionic product of water Kw one can readily calculate
the free zinc ion concentration or the pH of a solution of ε-Zn(OH)2
according to Eq. (12).
h
Zn2þðaqÞ
i
¼ KSO
OH
2 ¼ KSO

Hþ
2
K2w
(12)
When calculating the solubility of pH-sensitive solids such as
Zn(OH)2(s), it is important to include the effect of hydroxo complex
formation as a factor that increases the total solubility of Zn(OH)2(s)
(Fig. 2). Thus, solubility (S) is the sum of all the soluble species
discussed above at a particular pH value (Eq. (13)).S ¼ZnðH2OÞx2þ þ ZnðOHÞðH2OÞx1þ
þ ZnðOHÞ2ðH2OÞx2ðaqÞ þ hZnðOHÞ3 ðH2OÞx3i
þ ZnðOHÞ42where x ¼ 4 or 6
(13)
Concentrations of a particular species can be calculated based on
the individual dissociation constants for each step. However cu-
mulative formation constants (b1-4) are much more convenient in
practice in order to simplify the computation. According to this
notation b1 (K1), b2 (K1  K2) … are [Zn(OH)þ]/[Zn2þ][OH],
[Zn(OH)2(aq)]/[Zn2þ][OH]2… and their logarithmic values are 4.95
(b1), 9.20 (b2), 13.1 (b3) and 16.6 (b4). Since the effect of different
numbers of coordinated water molecules on these constants is not
known, water molecules are omitted here for clarity. When
combining Eq. (13) with the concentrations of particular zinc spe-
cies, the solubility of Zn(OH)2(s) is expressed by Eq. (14). Combining
the solubility and solubility constants (KSO) allows for calculation of
the total concentrations (sum of all Zn(II) forms, Zn2þ(aq)) of soluble
species at any given pH (Eq. (15)).
S ¼
h
Zn2þðaqÞ
i
1þ b1
h
OH
i
þ b2
h
OH
i2 þ b3hOHi3
þ b4
h
OH
i4
(14)
S ¼ KSO
 
1
OH
2 þ b1OHþ b2 þ b3
h
OH
i
þ b4
h
OH
i2!
(15)
Eq. (15) also allows for calculating the solubility of Zn(OH)2(s),
which is frequently considered as a completely insoluble zinc
species. In a presentation of the relationship between pH and the
solubility of zinc hydroxide (Fig. 3), the ordinate gives the sum of all
soluble zinc species [Zn2þ(aq)] present at variousmolar fractions at a
particular pH. For example, log values of the concentration of all
soluble Zn(II) species at pH 7 and 7.4 are 2.47 and 3.26, corre-
sponding to 3.4 and 0.55 mM, respectively. Even at pH ~10, where
the solubility of Zn(OH)2(s) is lowest, the concentration of soluble
zinc species is 0.13 mM. These values are much higher than what
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mentally, for example by using atomic absorption spectropho-
tometry [23]. A relatively high solubility of Zn(OH)2(s) is the reason
why addition of ZnSO4 or ZnCl2 at submillimolar concentrations to
a HEPES buffer (at a pH close to the pKa of the buffer) does not result
in precipitation. This fact turns out to be useful when preparing
solutions of these zinc salts for biophysical measurements [24].
Another important issue in zinc hydroxo complex chemistry is
olation, the formation of polynuclear species, such as [Zn2(OH)6]2-
and complexes of higher nuclearity. Polynuclear complexes are
formed rather slowly and many of them are kinetic intermediates
in the slow transition from soluble hydroxo mononuclear com-
plexes to a solid precipitate and are thus thermodynamically un-
stable. The formation of precipitates may be observed when storing
stock solutions of zinc salts. Their “aging” hasmany reasons, such as
formation of carbonates or mixed complexes, presence of impu-
rities, and it may also involve the formation of polynuclear species,
which are less soluble in water. Upon dilution, the fraction of
polynuclear zinc hydroxo complexes in aqueous solutions
decreases.
While this presentation of the chemistry of zinc aquo complexes
may seem quite involved, nevertheless it is fundamental to zinc in
biology and to the preparation of various solutions of zinc salts and
complexes for controlled and well-designed experiments in the
laboratory and for the feeding of organisms.
Zinc aquo complexes have to exchange their water molecules
when binding to other ligands. Binding to any protein site requires
such ligand exchange. It is particularly relevant when zinc is
transported as transport involes multiple ligand exchanges. The 3D
structure of the bacterial zinc transporter E. coli YiiP, which belongs
to the family of cation diffusion facilitators (CDF), shows that the
transported species apparently is a Zn2þ ion without bound water
molecules or LMW ligands when it is bound in the primary site to
one histidine and three aspartate side chains [25]. If a zinc ion
without ligands in transfer or transport in a protein exists tran-
siently, we suggest referring to it as a “naked” zinc ion to distin-
guish it from the “free” zinc ions with bound ligands in solution.
The energetics of ligand exchange therefore are critical to the
functioning of this and other zinc transporters. The properties of
the Zn-O bond in zinc bound-water molecules are at the center of
mechanisms of zinc metalloenzymes, in particular the modulation
of the pKa of the Zn2þOH2 to Zn2þOH transition, which pro-
vides the nucleophile for hydrolytic reactions.
Deprotonation of zinc aquo complexes leads to species with
different charges and they are important for interaction with pro-
teins. The pH dependent species of zinc aquo complexes are also
important when performing experiments with zinc compounds.
The acid-base properties need to be considered whenmaking stock
solutions of zinc salts or zinc complexes. The type of salt and its
concentrations are important with regard to whether or not
enough pH buffering capacity is available to keep zinc ions in so-
lution. When stock solutions of zinc salts in water or buffer are
added to culture media for cells or bacteria, the solubility and the
possible complexation by pH buffers and other components of the
media must be understood and considered.
Zinc compounds are used in nutritional studies of organisms.
ZnO, for example, has been used in the large age-related eye disease
study (AREDS) [26]. When using this compound, it is important to
know the chemical properties of the different commercially avail-
able products in the corresponding biological environment in order
to understand bioavailability. The physical properties, such as sol-
ubility and particle size, can vary signiﬁcantly for ZnO from
different suppliers. This variation also applies to manufactured ZnO
nanoparticles, which are now being increasingly employed in
feeding and investigated with regard to their effects on biologicalsystems.
One issue not addressed above is that a precipitate can be
formed when dissolving ZnCl2 in water. Despite the high solubility
of the salt, the precipitate is due to the formation of zinc oxy-
chlorides, of which at least 16 different forms have been described
[27]. One important form is tetrabasic zinc chloride (TBZC), zinc
chloride hydroxide monohydrate with the chemical formula
Zn5(OH)8Cl2,H2O [28]. It has a variety of applications in animal
feed, as a fungicidal additive to plant food and in medicine/
dentistry.
3.2. Biologically important anions
In natural waters, zinc speciation has been investigated widely
and Zn2þ(aq), ZnCO3o, ZnSO4o, Zn(OH)2, ZnClþ, ZnCl2, ZnCl3, and
ZnCl42 have been identiﬁed [29]. In this literature, the supscript (o)
refers to the soluble forms, ie. Zn(OH)2 ¼ Zn(OH)2(aq). The chemical
formulae do not indicate the bound water molecules. Thus, ZnClþ is
actually [ZnCl(H2O)x-1]þ according to the speciation and nomen-
clature discussed above. The concentrations of these species
depend on the pH of the aqueous solution, the anion concentra-
tions and the presence of dissolved organic matter (DOM), which
on average contributes with a logK of 6.4e7.0 with ligands such as
humic and fulvic acid. Chloride species become important with
increasing salinity. The concentrations of zinc hydroxo and carbo-
nato complexes increase above pH 7.5 and become the predomi-
nant species above pH 8. Sulﬁde also contributes, even in oxic
water. In anoxic water, ZnS nanoparticles and Zn-S clusters have
been identiﬁed: [Zn3S3(H2O)6] and [Zn4S6(H2O)4]4- [30,31]. It is
quite remarkable that the nuclearity of these complexes with re-
gard to zinc is exactly what is found in the two zinc-sulfur clusters
of mammalian metallothioneins.
Distribution of elements in blood often reﬂects their distribution
in sea water. However, within cells, a different milieu is maintained
as the concentrations of chloride and hydrogen sulﬁde (HS) are
kept relatively low, though the latter is a signalling substance and a
component of the structure of Fe-S clusters. Whether these anions
(Table 1) are involved in coordinating zinc ions or the presumable
coordination changes during zinc transport from/into cells is not
known. In the cell, these anions are also buffered, ie. there is a
controlled equilibrium between free and bound, though the term
buffering is not used in this context. Hydrogen sulﬁde is kept at
very low concentrations, but hydrogen phosphate (HPO42), sulfate
(SO42), hydrogen carbonate/carbonate (HCO3), and chloride are all
present at millimolar concentrations (Table 1). Hydrogen sulﬁde,
hydrogen phosphate, and sulfate are the strongest inorganic anions
for zinc (Fig. 4). There is also diphosphate (pyrophosphate, P2O74),
triphosphate (P3O105), tetraphosphate (P4O136), and inositol phos-
phate (section 4, Table 2), all of which bind zinc much more efﬁ-
ciently with apparent dissociation constants (pKd) of 2.7, 6.9, 7.2
and 10.4, respectively [32e35]. Acetate, carbonate, and chloride are
ligands with intermediate strength for coordinating with zinc ions,
and some anions are biological ligands of zinc in proteins. Free
acetate is expected to be very low as it is mainly in the form of
acetyl-CoA. Other organic acids that are metabolites can also serve
as potential ligands (Table 2). Hydrogen carbonate is a ligand in the
zinc enzyme carbonic anhydrase. Chloride has been identiﬁed as a
ligand of zinc in the crystal structures of some zinc proteins.
Chloride is likely to be a ligand in ternary complexes with other
ligands if expansion of the coordination sphere is possible.
Hydrogen phosphate interacts with zinc sites in metal-
lophosphatases. Chloride complexes are likely signiﬁcant in the
stomach, which contains up to 0.1 M HCl, whereas carbonate
complexes likely play a role in the duodenum where Brunner's
glands provide an alkaline secretion high in bicarbonate to
Table 1
Concentrations of simple biological and inorganic anions and stepwise formation constants for zinc anion complexes. Data refer to 25 C and I ¼ 0.1 M unless otherwise
speciﬁed.
Anion Cell (mM) Blood (mM) Zn(II) complex formation logK Reference
ClO4 n.d. n.d. [Zn(H2O)x]2þ þ ClO4$ [Zn(ClO4)(H2O)x-1]þ 1.58 [96]
NO3 n.d. n.d. [Zn(H2O)x]2þ þ NO3$ [Zn(NO3)(H2O)x-1]þ 0.12 [97]
Cl 4 116 [Zn(H2O)x]2þ þ Cl$ [ZnCl(H2O)x-1]þ
[ZnCl(H2O)x-1]þ þ Cl$ [ZnCl2(H2O)x-2]
[ZnCl2(H2O)x-2] þ Cl$ [ZnCl3(H2O)x-3]
[ZnCl3(H2O)x-3] þ Cl$ [ZnCl4]2-
0.43a
0.18a
0.1a
0.31a
[98,99]
HCO3 12 29 [Zn(H2O)x]2þ þ HCO3$ [Zn(HCO3)(H2O)x-1]þ
[Zn(H2O)x-1]2þ þ CO32$ [Zn(CO3)(H2O)x-1](aq)
0.85b
3.3a
[98,100]
OAc n.d. n.d. [Zn(H2O)x]2þ þ OAc$ [Zn(OAc)(H2O)x-1]þ 0.93 [101]
SO42- 0.3 0.27 (serum) [Zn(H2O)x]2þ þ SO42$ [Zn(SO4)(H2O)x-1] 2.34c [102e104]
Pi (pKa ¼ 7.21)d 0.5e5 0.8e1.5 [Zn(H2O)x]2þ þ HPO42$ [Zn(HPO4)(H2O)x-1](aq) 2.4 [95e107]
HS 15 nM n.d. [Zn(H2O)x]2þ þ HS$ [Zn(HS)(H2O)x-1]þ
[Zn(HS)(H2O)x-1]þ þ HS$ [Zn(HS)2(H2O)x-2](aq)
6.1e
4.1e
[108,109]
HO 0.1 mM n.d. [Zn(H2O)x]2þ þ OH$ [Zn(OH)(H2O)x-1]þ
[Zn(OH)(H2O)x-1]þ þ OH$ [Zn(OH)2(H2O)x-2](aq)
[Zn(OH)2(H2O)x-2](aq) þ OH$ [Zn(OH)3(H2O)x-3]-
[Zn(OH)3(H2O)x-3]2þ þ OH$ [Zn(OH)4]2-
4.95f
4.25f
3.9f
3.5f
[22]
n.d. e not determined.
a I ¼ 0 M.
b I ¼ 0.68 M.
c I is unknown.
d Pi refers to inorganic phosphate, which in water medium is H2PO4 in equilibrium with HPO42, pKa corresponding to H2PO4 dissociation is 7.21 [107].
e I ¼ 0.72 M.
f Constants determined in water from measurements by atomic absorption spectrophotometry.
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Fig. 4. The zinc binding abilities of biological anions. The bars demonstrate percent-
ages of free and complexed species, calculated for 0.1 M anion and 1 mM of total Zn2þ.
Light and dark grey colors refer to free and bound Zn(II) species, respectively.
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When preparing zinc salt solutions for biological experiments
the possibility of these anions forming zinc complexes and affecting
the outcome of the experiment(s) is signiﬁcant and should be
considered, in particular in the absence of other ligands with
competing afﬁnity for zinc. Physiological salt solutions are often
based on phosphates and so are cell culture media, which provide
ligands for zinc in the absence of serum. Considering speciation of
complexes with anions is not only important for bioavailability of
zinc ions but also for interactions with proteins, which may be very
speciﬁc and lead to either activation or inactivation of a biological
process. Sodium or potassium chloride added to biological buffers
to adjust their ionic strength will change zinc speciation, especially
in the absence of other ligands with high afﬁnity for zinc.
Perchlorate does not occur naturally in biological systems and ni-
trate concentrations are very low (Table 1). Other negativelycharged metal anion or oxoanion complexes may also form insol-
uble zinc complexes. Examples are [Fe(CN)6]4- or [Hg(SCN)4]2- used
in analytical chemistry to precipitate zinc ions.4. The complexation of zinc with ligands other than water
and the stability of zinc complexes
All biologically important molecules such as amino acids, pep-
tides, proteins, carbohydrates, nucleotides, DNA and RNA, and vi-
tamins contain atoms that can serve as electron pair donors for
metal coordination and therefore can be considered as potential
ligands for metal ion binding [36]. However, many interactions may
not be strong enough to be physiologically signiﬁcant. Accordingly,
the biological zinc chemistry has focused almost exclusively on
proteins.
Ligands are called monodentate if they possess only one donor
atom or donate just one of their available pairs of electrons to the
metal ion. They are called multidentate if they possess more than
two donor atoms. Multidentate ligands can form chelates, ring
structures of covalently linked donors around the central metal ion.
The highest stability is attained when 5- or 6-membered chelate
rings are formed. The prototype of a ligand that forms a 5-
membered chelate ring and occupies six coordination positions
around the zinc ion is ethylendiaminetetraacetic acid (EDTA). The
chelate effect makes an important contribution to enhancing the
stability of low molecular weight zinc complexes when compared
to monodendate complexes as it increases the entropy of the sys-
tem [37].
How stable zinc complexes are is determined by the (Gibbs) free
energy, which has an enthalpic and an entropic contribution.
Changes of either one affect complex stability (Eqs. (16) and (17)).
DG+ ¼ RT ln K ¼ DH+  TDS+; (16)
ln K ¼ DH
+  TDS+
RT (17)
The enthalpic contribution to complex stabilization derives from
the metal ion preference for particular donors. Such a preference
Table 2
The apparent dissociation constants and competitivity indices (CI)a of zinc complexes with common chemicals and natural products. Unless otherwise speciﬁed, the stability
values were determined at pH 7.4, I ¼ 0.1 M and 25 C.
Ligands Zinc ligand Complex
stoichiometryb
Donors c Apparent dissociation constant (Kd) pKd Competitivity Index (logCI)a References
pH buffers Tris ZnL NO* 3.29  102 M 1.48 1.48 [110]
Bis-Tris ZnL NO* 5.03  103 M 2.30 2.30 [111]
Bis-Tris propane ZnL NO* 1.19  104 M 2.93 3.32 [112]
ZnL2 N2O2* 2.15  106 M2 5.66
Bicine ZnL NO* 7.50  105 M 4.12 4.39 [88]
ZnL2 N2O2* 3.12  107 M2 6.51
Tricine ZnL NO* 6.47  105 M 4.19 4.19 [89]
Reductants TCEP ZnL O3P 3.29  103 M 3.29 3.29 [93]
b-Mercaptoethanol Zn2L3-Zn6L15 S2eS4 (S4) n.c. n.c. 3.60d [92]
DTT ZnL2, Zn3L4 (ZnL) S4 (S4) 2.83  1010 M2 9.55 8.32 [90]
DTBA ZnL2 (ZnL, Zn2L3) S4 (S4) 5.38  1013 M2 12.27 9.29 [91]
Carboxylic acids a-Ketoglutaric acid ZnL, ZnL2 O2, O4 ~2  102 M2 ~1.7 1.13d [113]
Pyruvic acid (pyruvate) ZnL, ZnL2 O2, O4 ~2  103 M2 ~2.7 1.26d [114]
Succinic acid (succinate) ZnL O2 2.54  102 M 1.60 1.60 [115]
Glutaric acid (glutarate) ZnL O2 2.52  102 M 1.60 1.60 [115]
Lactic acid (lactate) ZnL O2 1.38  102 M 1.86 1.86 [116]
Lipoic acide ZnL O2 3.7  103 M 2.43 2.43 [117]
Malic acid (malate) ZnL O2 1.52  104 M 3.82 3.82f [118]
Folic acid (folate) ZnL2 N2O2 2.2  106 M2 5.67 2.84g [119]
Oxalic acid (oxalate) ZnL O2 3.16  104 M 3.50 3.50 [120]
Orotic acid (orotate) ZnL NO 2.20  104 M 3.66 4.80f [121]
ZnL2 N2O2 2.40  108 M2 7.62
Dipicolinic acid ZnL NO2 5.74  104 M 3.24 8.70h [122]
ZnL2 N2O4 1.33  1012 M2 11.88
Citric acid (citrate) ZnL2 (ZnL) O6 (O6) 1.17  1012 M2 11.93 8.93 [41]
Amino acids Glutamic acid (glutamate) ZnL NO 2.85  103 M 2.54 2.70 [66]
ZnL2 N2O2 2.18  105 M2 4.66
Glycine ZnL NO 2.40  103 M 2.62 2.82 [87]
ZnL2 N2O2 1.29  105 M2 4.89
Aspartic acid (aspartate) ZnL NO 3.92  104 M 3.40 3.54 [44]
ZnL2 N2O2 4.13  106 M2 5.38
N-Ac-Cys ZnL2 (ZnL) O2S2 (OS) 6.77  108 M2 7.17 4.06 [123]
Histidine ZnL N2O 3.22  104 M 3.49 5.48 [40]
ZnL2 N4O2 3.05  109 M2 8.52
Cysteine ZnL2 (ZnL) N2S2 (NS) 9.77  1012 M2 11.01 7.84i [124]
D-penicillamine ZnL2 (ZnL) N2S2 (NS) 2.81  1012 M2 11.55 8.38i [124]
Nucleotides AMP ZnL NO 1.84  103 M 2.73 2.73 [125]
ADP ZnL NO2 9.73  105 M 4.38 4.38 [125]
ATP ZnL NO3 7.68  106 M 5.11 5.11 [125]
Redox buffers GSSG ZnL (Zn2L) N2O2 (NO) 5.3  105 M 4.28 4.28 [66]
GSH ZnL NOS 1.65  104 M 3.78 5.16 [126]
ZnL2 NOS2 8.74  109 M2 8.06
Bacillithiol ZnL NSO2* 4.0  106 M 5.40 9.05j [73]
ZnL2 N2S2* 5.38  1013 M2 12.27
Others Tetracycline ZnL O2 6.77  103 M 2.17 2.17f [127]
Carnosine ZnL NO 4.55  103 M 2.34 2.34 [128]
Oxytetracycline ZnL O2 2.24  103 M 2.65 2.65f [127]
Diphosphate
(pyrophosphate)
ZnL O2 1.91  103 M 2.72 2.72 [32]
Gentamicin C1a ZnL NO* 1.60  103 M 2.79 2.79 [129]
Histamine ZnL N2 2.98  103 M 2.53 2.96 [130]
ZnL2 N4 5.41  106 M2 5.27
Triphosphate ZnL O3 1.35  107 M 6.87 6.87 [33]
Tetraphosphate ZnL O4* 5.72  108 M 7.24 7.24 [34]
Pyrithione ZnL2 k (ZnL) O2S2 k (OS) 5.0  1012 M2 11.30 8.30 [76]
Phytic acid (phytate) ZnL O5* 3.7  1011 M 10.44 10.44 [35]
Nicotianamine ZnL N3O3 1.60  1011 M 10.48 10.48 [82,131]
a CI is the apparent dissociation constant of ZnZ complex (zinc complex of theoretical molecule Z), such that [ZnZ] ¼ Sijk [ZniHjLk], at a given overall component con-
centration. The concentrations of Z were set at 2 mM, and those of Zn2þ at 0.5 mM.
b Complexes in brackets are the minor species.
c Donors in brackets refer to complex as minor species.
d I ¼ 0.5 M.
e Dihydrolipoic acid (reduced form of lipoic acid) is assumed to bind Zn2þ more tightly.
f 37 C, I ¼ 0.15 M.
g 20 C, I ¼ 0.01 M.
h 20 C.
i I ¼ 0.2 M.
j Apparent dissociation constant determined at pH 7.7, I ¼ 0.15 M.
k Complex in crystals present as dinuclear Zn2L4 species with S3O2 donors. n.c. e not calculated. Asterisks denote putative donor atoms.
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two categories, A and B [38]. The grouping depends onwhether the
complex is more stable with a donor atom from a member of the
ﬁrst periodic group (F, O, N) or with a member of a subsequent
group (Cl, S, P). In this classiﬁcation, Zn(II) belongs into category B,
in which neither the charge nor the size of the interacting atoms/
ions is the primary reason for the stability. Stability of the complex
increases with the ionization potential of the metal (charge den-
sity) and with decreasing electronegativity of the ligand donors, ie.
the tendency of a ligand to donate electrons. In the series F, O, N, Cl,
Br, I, and S, the electronegativity decreases from left to right while
the stability of the complexes with zinc increases. In another
concept, metal ions and ligands are grouped into soft and hard
acids and bases (SHAB) depending on the degree of their polariz-
ability [39]. In this classiﬁcation, Zn(II) belongs to a borderline
category of acids with a tendency to form stable complexes with
moderately polarizable ligands (bases) such as nitrogen donors. The
borderline character of Zn(II) is also seen in its tendency to form
complexes with both hard oxygen and soft sulfur donors in bio-
logical complexes with low molecular weight (LMW) or high mo-
lecular weight (HMW) ligands. Zinc forms stable octahedral
complexes with L-histidine and citrate with oxygen and nitrogen
donors [40,41] as well as interacts with up to four sulfur donors
from cysteine residues in tetrahedral zinc-thiolate sites in proteins,
where binding can include nitrogen donors from histidine residues
[6,42]. Enthalpic effects on complex stability are frequently hidden
deep in the protein structure. Additional interactions such as
hydrogen bonding and electrostatic interactions within the ligand
formed during the complexation also affect the stability signiﬁ-
cantly [3,5,24,43].
The entropic contribution to complex stabilization derivesmostly
from the chelate effect mentioned above and the structure of the
protein or LMW ligand when it changes during complexation. The
chelate effect is particularly prominent in proteins when the zinc
binding site is not preformed. It can be readily seen in the
complexation of zinc with EDTA when six water molecules are
replaced by one ligand molecule of EDTA (Eq. (18)).

ZnðH2OÞ6
2þ þ EDTA2%ZnEDTA2 þ 4H2Oþ 2H3Oþ (18)
The increase in the number of ligands (products) provides an
entropic driving force for the reaction. The increased entropy is
associated with higher complex stabilization (Eq. (17)). Aside from
this chelate effect referring the formation of a ring structure, sta-
bility of zinc complexes can increase by a macrochelate effect,
which refers to entropic effects in the outer coordination sphere,
which is common in proteins.
Important issues for complex formation are the charge of the
ligand and its acid-base properties. Most of the biological ligands
possess acid-base properties and their complexation is linked to the
loss of proton(s) (Eqs.(19) to (21)).
RSHþMnþ%RSMðn1Þþ þ Hþ (19)
RNHþ3 þMnþ%RNH2 Mnþ þ Hþ (20)
RðCOOHÞNHþ3 þMnþ%RðCOOÞNH2Mðn1Þþ þ 2Hþ (21)
The strength of competition between metal ions and protons is
strictly related to the complex stability and the acid-base properties
of the ligand. In general, stabilities of complexes are higher at
higher pH because the competition between metal ions and pro-
tons decreases. The association or formation constant (K or Ka, unit
M1) or the dissociation constant (Kd, unit M) describe the stabilityof the complex at particular conditions (temperature and ionic
strength, I). If the constants describe the same equilibrium their
values are reciprocals: Ka ¼ 1/Kd. If complexation is associated with
the dissociation of protons, calculation of Ka or Kd requires
knowledge of the acid dissociation constants of the ligand donors.
Most of the biologically important metal complexation equi-
libria occur at a constant pH value, ie. they are pH-buffered. In this
case, the association constant is deﬁned in a much simpler way
(Eqs. ((22) and (23)). In order to differentiate between values that
refer to unbuffered and buffered conditions the latter values are
called apparent (Kapp or conditional constants referring only to a
particular pH value). Determination of apparent constants does not
require knowledge of the acid-base properties of the ligand (L),
which is a convenient way of describing binding properties of
macromolecules.
Lx þMnþ%MLxþn (22)
Kappa ¼

MLxþn

½LxMnþ (23)
With the known values of the pH-dependent association con-
stant and the acid dissociation constants one can calculate the
apparent constant at any pH value. This conversion is very impor-
tant in biology. For example, for the formation of the Zn-EDTA
complex (Ka ¼ 16.46), one calculates Kaapp ¼ 13.22 and 13.64 at pH
7.0 and 7.4, respectively (Fig. 5a) [44]. Ionic strength and temper-
ature also have a signiﬁcant inﬂuence on the stability of the com-
plex (Fig. 5b,c). The conversion of Ka to Kaapp is important when
using tabulated data of Ka, for example for zinc chelators (Table 3).
Their binding constants need to be converted to the proper con-
ditions of the experiment (pH, ionic strength and temperature).
In order to determine apparent stability constants of the agents
that potentially interact with Zn2þ one needs a readout such as a
change of absorbance, ﬂuorescence, ellipticity etc. upon Zn2þ
binding. The constants can be determined in direct titration ex-
periments if the afﬁnity of Zn2þ towards the molecule of interest is
not lower than ~108 M. This value depends on the physicochem-
ical property investigated under Zn2þ binding and the ratio be-
tween the maximal and minimal value of the measured parameter,
i.e. the sensitivity, and the concentrations of reactants. Indirect
determinations can be performed in zinc-buffered media. In both
applications, knowledge about the stoichiometry of the interaction
is required as it affects the numeric value and unit of the constant.
Such information can be obtained by Job's method of continuous
variation [45]. Metal buffers are solutions of chelating agents with
various amounts of total zinc and they are chosen for buffering in
certain pZn ranges (Table 3). Ideally they form 1:1 complexes.
Control of pZn values from the low attomolar range in the case of
TPEN to micromolar in the case of IDA is possible. The values of pZn
are calculated by Eq. (3) and depend on pH, temperature and ionic
strength. The calculation can be performed using any of the avail-
able programs, such as the simplest, MaxChelator, or more
advanced ones such as MINEQLþ and Hyperquad Simulation and
Speciation software [46e49]. All mentioned programs contain sets
of stability data for various metal ions under various conditions.
The more advanced software allows for developing models based
on a particular chelator or the stability determined at various
conditions. The most common format available in those software
packages are conditional (not apparent) pH-independent constants
that are tabulated from several databases such as those from IUPAC,
NIST, or the Martell and Smith compendium [44]. Results are usu-
ally presented as pZn as a function of the investigated physical
parameter and are ﬁtted to single or multiple binding models using
Fig. 5. The dependence of the dissociation constant of the [Zn(EDTA)]2- complex on experimental conditions used for its determination such as pH (a), ionic strength, I (b) and
temperature (c). Red, black and blue colors in b) and c) correspond to pH 7.0, 7.4 and 8.0, respectively.
Table 3
The apparent dissociation constantsa of zinc complexes with widely used zinc chelators and ﬂuorogenic or chromophoric probes with pZn ranges of their application.b Unless
otherwise speciﬁed, the stability values were determined at pH 7.4, I ¼ 0.1 M and 25 C. Stoichiometry is simpliﬁed to ZnLx without protonation state.
Chelator/probe Donors Complex stoichiometry Apparent dissociation constant (Kd) log Kd (pKd) pZn range of the application References
Zinc chelators TPEN N6 ZnL 6.4  1016 M 15.2 14.2e16.2 [44]
DTPA N2O4 ZnL 5.6 1015 M 14.3 13.3e15.2 [44]
EDTA N2O4 ZnL 2.3  1014 M 13.6 12.7e14.6 [44]
HEDTA N2O3 ZnL 6.6  1013 M 12.2 11.2e13.1 [44]
EDDSc N2O4 ZnL 2.3  1011 M 10.6 9.7e11.6 [44]
BAPTA N2O4 ZnL 4.9  1010 M 9.3 8.4e10.3 [132]
EGTA N2O4 ZnL 6.3  1010 M 9.2 8.2e10.2 [44]
EDDA N2O2 ZnL 1.2  109 M 8.9 8.0e9.9 [44]
NTA NO3 ZnL 4.4  109 M 8.4 7.4e9.3 [133]
Cyclamd N4 ZnL 2.0  109 M 8.7 7.5e9.5 [134]
IDA NO2 ZnL 3.2  105 M 4.5 5.3e6.8 [135]
N2O4 ZnL2 4.8  109 M2 8.3
Fluorescent probes FluoZin-3 N2O3 ZnL 8.9  109 M 8.1 7.1e9.0 [9]
RhodZin-3 N2O3 ZnL 1.4  109 M 8.9 7.9e9.8 [136]
ZnAF-1 N4 ZnL 7.8  1010 M 9.1 8.2e10.1 [137]
ZnAF-2 N4 ZnL 2.7  109 M 8.6 7.6e9.5 [137]
ZnAF-1F N4 ZnL 2.2  109 M 8.7 7.7e9.6 [137]
ZnAF-2F N4 ZnL 5.5  109 M 8.3 7.3e9.2 [137]
Zinpyr-1e N3O ZnL 7  1010 M 9.2 8.2e10.1 [138]
Zinpyr-4e N4 ZnL 6.5  1010 M 9.2 8.2e10.1 [139]
NBD-TPEAf N5 ZnL 2  109 M 8.7 7.8e9.7 [140]
Zinbo-5f N3O ZnL 2.2  109 M 8.7 7.7e9.6 [141]
Fura-2f N2O4 ZnL 3  109 M 8.5 7.5e9.4 [142]
Mag-Fura-2 NO3 ZnL 2  109 M 8.7 7.7e9.6 [143]
NewPort Green DCFg N3 ZnL 1  106 M 6.0 5.1e6.9 [144]
NewPort Green PDXe N3 ZnL 4  105 M 4.4 3.9e5.4 [145]
Zinquinh N4 ZnL 3.7  107 M 6.4 7.0e9.3 [146]
ZnL2 8.5  1013 M2 13.1
Chromophoric probes Zincon N2O2 ZnL 1.3  105 M 4.9 4.2e5.9 [147]
PAR N2O ZnL 2.75  105 M 4.6 7.3e9.4 [148]
N4O ZnL2 7.08  1013 M2 12.2
a Dissociation constants of ZnL and ZnL2 are deﬁned as [Zn2þ][L]/[ZnL] and [Zn2þ][L]2/[ZnL2], respectively.
b The pZn range for application of a particular chelator/probe refers to free zinc values (log[Zn2þ]free) corresponding to 0.9mM: 1mMe0.1 mM: 1mMmolar ratio (Zn2þ: L)
range. For IDA the application range refers to 0.45 mM: 1 mMe0.05 mM: 1 mM molar ratio range. In the case of Zinquin and PAR, the pZn range corresponds to 10 mM:
4.5 mMe10 mM: 0.5 mM and 100 mM: 45 mMe100 mM: 5 mM, respectively due to limited solubility and typical range of use. It should be noted that the range of application for
some probes is wider due to a higher signal upon Zn2þ binding. For those probes, free zinc below 10% of probe saturation can be measured.
c T ¼ 20 C.
d I ¼ 0.2 M.
e pH ¼ 7.0.
f pH ¼ 7.5.
g Experimental pH value unknown.
h Data determined in HBBS buffer.
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Software Corporation), DynaFit (BioKin Ltd). Frequently, data areﬁtted to Hill's equation that allows for evaluation of whether or not
the process involves cooperativity in binding [50]. Two conditions
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interference of the metal buffer with the reaction must be negli-
gible. If it is not negligible calculation must include the distribution
between the metal buffer and the ligand under investigation.
Calculations with stability constants become more complexes
for stoichiometries other than 1:1 between metal ion and ligand.
For instance, most amino acids form ZnL, ZnL2, or even ZnL3 com-
plexes with zinc ions. Formation of each complex is deﬁned by a
separate equilibrium, leading stepwise to the complexes, ie. ZnL2 is
formed by association of a ligand molecule to the ZnL species (K2)
and ZnL3 is formed from ZnL2 (K3). The formation of ZnL2 also can
be described by the cumulative formation constant b(ZnL2) which
is K1  K2. Frequently, b values are given as association and disso-
ciation constants but then their units differ from those of M1 and
M. Thus, dissociation of the ZnL2 complex to Zn2þ and two mole-
cules of L has the unit M2. The pH-dependent, stepwise or cumu-
lative association constants also require knowledge of the acid-base
properties of the ligand in order to calculate the apparent values of
ZnL, ZnL2 and ZnL3 complexes (K1app, K2app, K3app or b(ZnL)app,
b(ZnL2)app and b(ZnL3)app). All these equilibria, which differ for li-
gands, cause a signiﬁcant problem for comparison of zinc afﬁnities
of ligands that form complexes with various stoichiometries. A
straightforward comparison of binding ability can be performed
only for apparent constants of complexes with the same stoichi-
ometry. In order to be able to compare complexes with different
stoichiometries, the concept of a competitivity index has been
introduced [40]. Accordingly, all zinc complexes at particular con-
ditions with various stoichiometries and protonation states are
summed up and treated as a complex of a virtual molecule Z (Eq.
(24)). The Competitivity Index (CI) is then the dissociation constant
value of the MZ species deﬁned by Eq. (25).
½MZ ¼
X
ijk

MiHjLk

(24)
CI ¼ ½MZ½M½Z (25)
This concept, with all its limitations, allows comparison of
simple ligands with much more complicated ones in terms of their
protonation and stoichiometry at a particular pH value. CI indices
are included in Table 2 and provide a convenient means of
comparing zinc binding ability of the number of pH buffer com-
ponents, disulﬁde reductants, carboxylic acids, amino acids, nu-
cleotides, natural redox buffers, antibiotics, etc.
The pH dependence of complexation has important implications
for biology because there are signiﬁcant differences of pH values in
different organs and even in different cellular compartments.
Increasing the pH value causes deprotonation of a ligand with acid-
base properties and complexation while decreasing the pH has the
opposite effect. The acid-base properties of the ligand change with
complexation: strong binding perturbs the pKa considerably while
weaker binding has a smaller inﬂuence on the pKa value of the
ligand.
5. The coordination of zinc in the “free” zinc pool
While the ﬁrst part of this article addressed the chemical prin-
ciples of zinc coordination (water, anions, and other ligands) as
relevant for biology, the second part ampliﬁes the subject of bio-
logical signiﬁcance, in particular (i) the speciation of zinc ions
in vivo and the few instances where LMW ligands interacting with
zinc have been identiﬁed for speciﬁc functions and (ii) the coor-
dination chemistry of the LMW “tools” employed for investigating
zinc ions in biology.Ligands of the pool of cellular “free” zinc ions (not protein-
bound) and the ligands of zinc ions during transport or transfer
are generally not considered and knowledge is very limited though
some investigations indicate a role of speciﬁc complexes. It is a
fundamentally important issue which zinc species proteins recog-
nize, and it may be a key to speciﬁcity, but a lack of methods to
investigate speciation at the very low concentrations of zinc ions
has precluded progress. However, there are at least two reports
where extracellular interactions of speciﬁc species of zinc with
proteins have been investigated. For example, it has been demon-
strated that a particular species of zinc(II) is involved in metal as-
sociation with a protein. The species Zn(His)þ was found to be the
preferred substrate for membrane transport, suggesting a role of
amino acids in biological zinc complexation [51]. Histidine forms
1:1 and 2:1 complexes with zinc (Table 2, Fig. 6). The 2:1 complex
Zn(His)2 has no overall charge. The species relevant for inhibition of
carboxypeptidase A was identiﬁed as Zn(OH)þ [19]. In importance
of zinc speciation and overall charge of the zinc complex has been
demonstrated by an investigation into the efﬁcacy of zinc lozenges
to treat the common cold. Neutral zinc complexes had no effect,
negatively charged zinc complexes worsened the outcome, and
only positively charged zinc complexes were efﬁcacious [52]. It has
been discussed that the rates of zinc transfer would be low on a
biologically meaningful time scale at the very low concentrations of
zinc ions prevailing in the cytosol. For instance, if concentrations
were as lowas 1 pM, zinc dissociation rates would be in the order of
14 h, assuming diffusion-controlled association rates [53]. At least
two pathways are envisioned to overcome this dilemma. One is
direct associative transfer between proteins as has been observed
for transfer of zinc between metallothioneins and for transfer or
other metal ions by metallochaperones, and the other is a role of
LMW compounds in “catalyzing” zinc transfer. Such an enhance-
ment of zinc transfer has been observed in model reactions where
compounds that have afﬁnities between those of the zinc donor
and the zinc acceptor facilitate metal transfer [54,55]. Evidence for
such reactions being biologically relevant came from the observa-
tion that carbonic anhydrase, which exchanges zinc very slowly (t1/
2 > 100 days), equilibrates rapidly in the cell [56].
Glutathione, ATP, citrate, and amino acids are all candidates for
chelating ligands in the LMW pool of zinc (Fig. 6). Evidence for
involvement of ATP as a ligand of zinc has been provided, thus
demonstrating in principle how biological speciﬁcity by LMW
species can be achieved. Some kinases phosphorylating vitamins
prefer a ZnATP complex over a MgATP complex [57]. In the crystal
structures of ﬂavokinase and pyridoxal kinase a bound ZnATP
complex was detected [58,59]. ATP forms a rather stable complex
with zinc because the N7 of the adenine moiety provides an
additional ligand (Kd and CI value of the ZnL complex is
7.68  106 M; Table 2, Fig. 6) [60,61].
Glutathione (GSH) as a ligand is particularly intriguing for
conferring speciﬁcity in metal transfer reactions as zinc forms a
variety of complexes with GSH (Kd of 8.74  109 M2 for the ZnL2
complex corresponding to alogCI value of 5.16, Table 2, Fig. 6) as a
function of pH and GSH concentrations, including ternary com-
plexes [40,62,63]. GSH has been discussed as a ligand of the LMW
Fe(II) pool [64].
Further exploration of whether or not complexation or changes
in complexation of zinc ions determines speciﬁcity in biological
processes is an important issue for understanding how zinc is
provided to proteins for binding, how cellular sensors and trans-
porters recognize zinc, and for how and where zinc expresses its
function as a signalling ion at target sites in proteins [65]. In the
absence of knowledge of the coordination of zinc in the LMW zinc
pool, virtually all experiments employ zinc salts in biological
buffers without recognizing that the species of zinc in such
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Fig. 6. Examples of structures of zinc complexes with low molecular weight biological ligands.
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One important aspect of the homeostatic control and re-
distribution of zinc in humans is its storage in cellular vesicles,
which are solute compartments with properties different from the
cytosol. In most instances, it is not known in which chemical form
zinc is stored in intracellular vesicles, and how its coordination
changes once it is released from the vesicles. Vesicular exocytosis
releases zinc into the extracellular ﬂuid, and brings zinc into a
biological compartment that provides different coordination envi-
ronments. In zinc-rich neurons in the brain, zinc is co-released with
glutamate from vesicles that are loaded with zinc by the trans-
porter ZnT3. Whether zinc forms a complex with glutamate in the
vesicles is not known. The Kdapp of the ZnL2 complex with glutamate
is 2.18  106 M2, with a logCI value of 2.7 corresponding to the
strength of the interaction of zinc with HPO42 (Table 2) [66]. Pre-
liminary investigations of zinc-rich vesicles by extended X-ray ab-
sorption ﬁne structure (EXAFS) spectroscopy demonstrated O, N,
and S-coordination [67]. Presumably, at the lower pH value in the
vesicles zinc ions are more weakly bound. Upon exocytosis zinc is
released into the synaptic cleft, which has a higher pH, and thus it is
expected to be bound more tightly. In the endocrine pancreas, zinc
is transported into insulin-containing secretory granules of b-cells
by the transporter ZnT8, where it has a role in storing crystalline
insulin as a hexamer with two bound zinc ions. The coordination
environment of zinc depends onwhether the hexamer is in the R orin the T state. Zinc is co-secreted with insulin (and amylin), and
monomeric insulin coordinates zinc with a Kd of 0.4 mM [68]. In the
exocrine pancreas and in epithelia of mammary glands, the trans-
porter ZnT2 loads the vesicles with zinc. In the exocrine pancreas,
zinc it thought to have a role in inhibiting proteases stored in these
vesicles. In the mammary glands, vesicular zinc is exocytosed into
the milk. In addition to being bound to proteins, zinc is bound in a
LMW pool in milk, which has been identiﬁed as a zinc-citrate
complex in humans [69,70]. Zinc ions form ZnL and ZnL2 com-
plexes with citrate with different overall charges. The ZnL2 complex
is favored because its Kd is 1.17  1012 M2 corresponding to
a logCI value of 8.93 (Table 2, Fig. 6) [41]. Micromolar concen-
trations of picolinate were also found in human milk and a zinc-
picolinate complex was isolated [71]. The prostate is another or-
gan where zinc is secreted from vesicles into the prostate ﬂuid. In
the prostate, zinc inhibition of aconitase is thought to be respon-
sible for the accumulation of citrate, which could serve as a zinc
ligand in prostatic secretion and in seminal ﬂuid [72]. The coordi-
nation environment of zinc in other zinc-storing vesicles and its
change when secreted from a variety of other zinc-secreting cells is
not known, nor is it known inwhich form cytosolic zinc is provided
to the ZnT transporters. The LMW ligands of zinc in urine, blood or
other biological ﬂuids have not been identiﬁed.
It is not known to which extent LMW ligands participate in zinc
buffering, whether zinc buffering occurs exclusively by proteins,
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buffering capacity changes and the pZn differs in different cell
types.
Bacillithiol has been identiﬁed as an important component of
zinc buffering in some bacteria [73]. It forms a ZnL2 complex with
an apparent Kd of 5.38 1013 M2 (logCI ¼ 9.05). Like glutathione
it is a redox active component of the LMW zinc pool, linking the
availability of zinc from this pool to the redox state of the cell. Thus,
not only is the protein pool with zinc coordination to sulfur redox-
sensitive, but also the LMW pool.
There is evidence for the participation of metallochaperones and
metallophores in the acquisition and redistribution of zinc. The
nomenclature is not consistent. Metallochaperones are proteins.
Based on the deﬁnition that metallochaperones metallate apopro-
teins to make metalloproteins metallothioneins classify as zinc
chaperones. However, the term has also been used for chemically
synthesized LMW compounds that can deliver zinc from the blood
to cellular proteins owing to (i) afﬁnities between those of blood
proteins such as albumin and cellular zinc metalloproteins and (ii)
being sufﬁciently hydrophobic to cross biological membranes, i.e.
they are ionophores [74]. Metallochaperones for zinc have been
identiﬁed in the periplasmic space of bacteria [75]. It is a pressing
issue whether or not, and if so under which circumstances, met-
allochaperones for zinc are required in eukaryotes. Employing zinc
chaperones may not to be an obligatory process in zinc re-
distribution in eukarya as too many chaperones would be
required to provide speciﬁcity for interaction with the about 3000
predicted human zinc proteins.
Zincophores similar to the established siderophores (Fe) and
chalcophores (Cu) have been described. Zincophores are different
from ionophores that transport zinc through the membrane, such
as pyrithione which forms a neutral ZnL2 complex (Fig. 6) with an
apparent Kd of 5.0  1012 M2 (logCI ¼ 8.30, Table 2) [76]. Zin-
cophores are typically found in bacteria that need to acquire Zn2þ in
an environment with either low zinc concentrations or high
competition for zinc. Hence, they need relatively high afﬁnity to
scavenge zinc ions. One zincophore is ethylene-N,N0-dia-
minedisuccinic acid ([S,S]-EDDS) [77], which has a Kd of
2.3  1011 M (logCI ¼ 10.6, Table 3). Its high afﬁnity for zinc is
comparable with common chelators such as EGTA and HEDTA [44].
Evidence is now accumulating that some siderophores also may
actually be zincophores [78]. The term zincophore has been
employed for the protein Pra1 secreted from C. albicans and
involved in scavenging Zn2þ [79]. Pra1 has orthologues in other
fungi but not in vertebrates. The complexation chemistry of zin-
cophores is important because they compete with the host for zinc.
Therefore, it may be possible to develop new therapeutic agents
with antibacterial/antifungal activities.
It is known in the scientiﬁc community but not widely
acknowledged for practical purposes that several antibiotics bind
zinc, e.g. tetracycline and gentamicin (Table 2). When antibiotics
are prescribed to treat infections or given prophylactically, the
interaction with zinc may be an issue for their efﬁcacy and/or
affecting zinc availability and thus the nutritional zinc status of the
host. In fact, the importance of this mechanism of action has been
demonstrated for vancomycin, which restricts the access of bacteria
to zinc [80].
Nicotianamine, an amino acid derivative and a precursor of
siderophores, is involved in zinc (and iron) metabolism in plants
[81]. Its apparent Kd is 1.6 1011M (Table 2) [82]. It transports zinc
from roots to shoots and is also secreted from the roots in metal
hyperaccumulator plants [83]. In this case, instead of being a
chelating agent for uptake of a metal, it is secreted to serve as a
chelating agent for the excess zinc in order to avoid further uptake.
This principle is related to that of other compounds that areantagonists of zinc uptake such as phytate (inositol hex-
aphosphate). Its Kd is 3.7  1011 M (Table 3) [35].
6. The coordination chemistry of “zinc tools”
The “tools” for investigating zinc in biology include at least three
types of agents: (i) chelating agents to remove zinc ions or buffer
zinc in certain ranges of pZn, (ii) pharmacological agents such as
ionophores to transport zinc through cellular membranes and
deliver zinc in a bioavailable form, and (iii) chromophoric and
ﬂuorescent probes to investigate zinc-dependent processes
(Table 3).
The strategy of designing zinc probes is well established and the
properties of the probes such as sensitivity, selectivity and afﬁnity
have been discussed widely [84]. One major principle is that a
chelating agent is coupled to a ﬂuorophore and once zinc is bound,
ﬂuorescence is “turned on.” The tools were developed without
prior knowledge of the properties of the biological pools of zinc and
accordingly a lot of discussions ensued which species they actually
measure. For example, probes and sensors purported to measure
“free” zinc ions can compete with protein-bound zinc and/or their
response can be modiﬁed by binding other ligands [65,85]. For
future investigations, it is important that knowledge of zinc
speciation informs the development and application of tools.
Two compounds are widely used in zinc biology: 2-
mercaptopyridine-N-oxide (pyrithione) (Fig. 6), which is an iono-
phore and employed to increase cellular zinc ion concentrations,
and N,N,N0,N0-tetrakis(2-dipyridylmethyl)ethylenediamine (TPEN),
which is a membrane-permeable chelating agent that is employed
to bind cellular zinc in order to make it unavailable for other pro-
cesses (Kd at pH 7.4 is 6.4  1016 M for the ZnL complex, Table 3)
[44]. Both agents are used to calibrate cellular zinc probes and
sensors by saturating their binding sites (with pyrithione) and by
removing their zinc (with TPEN).
Chelating agents are also used as zinc buffers in experimental
investigations. Chelating agents that can be employed for buffering
zinc over a wide range of pZn values (4.2e16.2) are available and
will be an essential tool for future investigations (Table 3).
There are two common issues with zinc complexation when
using biological buffers. One is that many pH buffers serve as li-
gands of zinc. Phosphate buffer forms ZnHPO4 (Table 2) and then
Zn(OH)2(s) or insoluble zinc phosphates depending on the actual pH
of the buffer and zinc concentrations. Another frequently used
buffer, Tris, also forms a weak ZnL complex (Kd ¼ 33 mM, Table 2).
Many Good's buffers have nitrogen donors and bind zinc [86].
HEPES has a sulfonate group that serves as an oxygen donor.
Glycine binds zinc with millimolar afﬁnity at neutral pH and much
stronger (micromolar afﬁnity) at pH 9, the region in which it is
typically employed as a pH buffer (Table 2) [87]. Bis-tris, bis-tris
propane, bicine and tricine bind zinc much more efﬁciently than
Tris. The Kd values for bicine and tricine are ~105 M at pH 7.4
(Table 2) [88,89]. Thus in any zinc competition experiment with
moderately strong zinc-binding ligands, the zinc binding capacity
of pH buffers needs to be considered. The second issue is the use of
reducing agents that are necessary at relatively high concentrations
to provide a reducing environment similar to the one in cells. The
reducing agent, especially if it is based on thiols, may bind zinc
tightly and thus remove zinc from the protein. Also, zinc binding
changes the redox properties of the reducing agent. Dithiothreitol
(DTT, Cleland's reagent) is widely used for many standard biological
buffers. It forms several complexes with zinc with various stoichi-
ometries and with coordination involving its two thiolates. Its af-
ﬁnity towards zinc measured by the CI index is nanomolar
(logCI ¼ 8.3, Table 2) [90]. A recently introduced reagent dithio-
butylamine (DTBA), similar in structure to DTT, binds Zn(II) even
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[91]. Two other reductants frequently used bind zinc less tightly
with submillimolar afﬁnity: 2-mercaptoethanol and tris carbox-
yethyl phosphine (TCEP), which has a more negative redox po-
tential [92,93].
7. Conclusions
Zinc-ligand bonds involve the spherical 4s electron shell and
have about 20% covalent character [94]. A consequence is that the
zinc ion is stereochemically inactive and quite ﬂexible regarding
coordination numbers with coordination dynamics that do not
underlie the stereochemical constraints typical for the transition
metal ions. It is also different frommagnesium (Mg2þ) and calcium
(Ca2þ) as it forms much stronger complexes with water and a va-
riety of anions and ligands. These characteristics are important for
its biological functions. The simultaneous presence of other metal
ions and anions in the biological environment sets constraints on
the stability of zinc/protein complexes. Zinc exchange kinetics can
be restricted in proteins, but the generally fast ligand exchange
kinetics endow zinc with characteristics well suited for signalling
and re-distribution on biological time scales. The different zinc
complexes discussed here are important in zinc transfer between
the different pools. Minimally, these pools include equilibria be-
tween several species (Eq. (26)).
Zn2þðaqÞ or Zn anionðsÞ%
Zn LMW chelates ð%Zn ChaperoneÞ%Zn Protein
Changes in zinc species are important when zinc is transported
through membrane proteins. Hydration chemistry and the ioniza-
tion of its bound water are important for its function in enzymes
(Zn-OH as a nucleophile), where it also forms complexes with an-
ions and chelating ligands. Furthermore, knowledge of zinc species
informs the formulation of zinc complexes for use in animal feed,
where often ZnO is used, for bioavailability when supplemented in
the human diet [95], when performing experiments with cultured
cells to increase cellular zinc, to treat a zinc deﬁciency, or when
chelating agents are employed to decrease zinc concentrations.
Knowledge of zinc chemistry impacts many areas, e.g. nutrition,
toxicology, and pharmacology. It is anticipated that different zinc
species provide biological speciﬁcity. Finally, it is a pressing issue to
determine zinc species to understand transporter characteristics,
zinc sensing, and zinc signalling. In the absence of knowledge about
LMW ligands, virtually all experiments are performed with zinc
salts and thus inappropriate substrates for biological interactions.
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